ALGORITHM OF DIAGNOSTICS AND TREATMENT OF JUVENILE ARTHRITIS
Abstract
The theme of the article is one of the most wide-spread rheumatologic diseases — juvenile arthritis (JA). It highlights main questions on epidemiology, classification, pathogenesis of the disease. Authors describe clinical symptoms of different types of JA, diagnostics and differential diagnosis. There is a part of an article with information on drugs used in patients with JA and the algorithm of differentiated treatment of a disease is presented. Authors paid special attention to approaches to biological therapy, conditions for the treatment and management of patients treated with genetically engineered biological drugs.
Key words: children, juvenile rheumatoid arthritis, juvenile arthritis, treatment, infliximab, adalimumab, etanercept, rituximab, abatacept, tocilizumab.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(6):78-104)
Key words: children, juvenile rheumatoid arthritis, juvenile arthritis, treatment, infliximab, adalimumab, etanercept, rituximab, abatacept, tocilizumab.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(6):78-104)
About the Authors
E.I. Alexeeva
Scientific Center of Children’s Helath, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
T.М. Bzarova
Scientific Center of Children’s Helath, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
Review
For citations:
Alexeeva E., Bzarova T. ALGORITHM OF DIAGNOSTICS AND TREATMENT OF JUVENILE ARTHRITIS. Current Pediatrics. 2010;9(6):78-104.
Views:
801
Email this article 
